Genentech Holds Out for Better Offer, Which Could Deliver a Boost to Biotech ETFs
August 14, 2008 – Biotechnology stocks and exchange traded funds (ETFs) could get a shot in the arm, as Genentech (DNA) rejected a takeover bid from Roche, which they feel has undervalued the company. Roche, the Swiss pharmaceutical company, offered... Continue Reading »

Five ETFs That Have Beared The Current Market
August 5, 2008 – Anyone who follows the markets knows that while some exchange traded funds (ETFs) might be down, other areas and ETFs are heading in the other direction. In our current bear market, there have bee several ETFs... Continue Reading »

Biotech ETFs Are a Matter of Personal Choice
July 27, 2008 – Biotechnology appeals to many investors, and with four different exchange traded funds (ETFs) focused on the class, is there a fund that is better than the rest? The sector is one of the few non-commodity related... Continue Reading »

Biotechnology ETFs Growing…Like Genetically Modified Crops?
July 16, 2008 – Biotechnology is the non-commodity exchange traded fund (ETF) area du jour, it seems. In a time where the markets seem bleak, the sector is delivering a ray of light. Genentech (DNA) this week upped its 2008... Continue Reading »

Can Biotech And Agriculture ETFs Get Acreage With Your Money?
July 10, 2008 – Not many exchange traded funds (ETFs) outside those focused on commodities are perched above their 200-day moving averages. That makes it worth noting that two biotechnology ETFs crossed the mark recently. Both iShares Nasdaq Biotechnology (IBB)... Continue Reading »